NASDAQ:PRPH - ProPhase Labs Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.0150 +0.10 (+3.43 %)
(As of 02/21/2019 01:02 PM ET)
Previous Close$2.92
Today's Range$3.00 - $3.0453
52-Week Range$2.30 - $6.64
Volume7,541 shs
Average Volume4,805 shs
Market Capitalization$34.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPH
CUSIPN/A
Phone215-345-0919

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.87 million
Cash Flow$1.2306 per share
Book Value$2.56 per share

Profitability

Net Income$40.58 million

Miscellaneous

Employees46
Market Cap$34.82 million
OptionableNot Optionable

ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How often does ProPhase Labs pay dividends? What is the dividend yield for ProPhase Labs?

ProPhase Labs announced a special dividend on Thursday, December 27th. Stockholders of record on Thursday, January 10th will be given a dividend of $0.25 per share on Thursday, January 24th. The ex-dividend date of this dividend is Wednesday, January 9th. View ProPhase Labs' Dividend History.

How will ProPhase Labs' stock buyback program work?

ProPhase Labs announced that its board has approved a share repurchase plan on Saturday, November 11th 2017, which authorizes the company to buyback 1,700,000 outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through a tender offer. Stock buyback plans are usually a sign that the company's board of directors believes its stock is undervalued.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs Inc (NASDAQ:PRPH) posted its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $2.44 million for the quarter. ProPhase Labs had a negative return on equity of 4.87% and a negative net margin of 11.41%. View ProPhase Labs' Earnings History.

When is ProPhase Labs' next earnings date?

ProPhase Labs is scheduled to release their next quarterly earnings announcement on Wednesday, March 20th 2019. View Earnings Estimates for ProPhase Labs.

Has ProPhase Labs been receiving favorable news coverage?

News stories about PRPH stock have trended somewhat negative on Thursday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ProPhase Labs earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.

Who are some of ProPhase Labs' key competitors?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the folowing people:
  • Mr. Ted William Karkus, Chairman, CEO & Director (Age 60)
  • Ms. Monica Brady, Chief Accounting Officer (Age 42)

Who are ProPhase Labs' major shareholders?

ProPhase Labs' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (0.12%) and Dimensional Fund Advisors LP (0.09%). Company insiders that own ProPhase Labs stock include Braden Michael Leonard, Jason Michael Barr, Robert V Cuddihy Jr and Ted William Karkus. View Institutional Ownership Trends for ProPhase Labs.

Which major investors are selling ProPhase Labs stock?

PRPH stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC. View Insider Buying and Selling for ProPhase Labs.

Which major investors are buying ProPhase Labs stock?

PRPH stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. View Insider Buying and Selling for ProPhase Labs.

How do I buy shares of ProPhase Labs?

Shares of PRPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of PRPH stock can currently be purchased for approximately $3.0150.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $34.82 million and generates $9.87 million in revenue each year. ProPhase Labs employs 46 workers across the globe.

What is ProPhase Labs' official website?

The official website for ProPhase Labs is http://www.prophaselabs.com.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]


MarketBeat Community Rating for ProPhase Labs (NASDAQ PRPH)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  76 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  168
MarketBeat's community ratings are surveys of what our community members think about ProPhase Labs and other stocks. Vote "Outperform" if you believe PRPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel